Bantam has a unique opportunity to provide meaningful benefits to cancer patients with significant unmet needs.
We are seeking partners and investors to join us as we progress our lead candidate BTM-3566 into clinical trials, expand into new indications and discover additional novel drugs.
Get in touch to learn more and speak with one of our team.
Get in touch
Our Science
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
Top linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram